Renato Arruda (@arrudarenato) 's Twitter Profile
Renato Arruda

@arrudarenato

MD, MSc
Neurologist
Headache Disorders | Education | Research

ID: 62534975

calendar_today03-08-2009 15:06:27

97 Tweet

135 Followers

331 Following

Robert Shapiro (@headachedoc) 's Twitter Profile Photo

.NIH posted updated data for research funding vs disease burden for 74 diseases. Since the first analyses (2010), #migraine is always least funded among highest burden diseases. If burden was the only factor, migraine funding might be >13 times higher. bit.ly/3AAvJgz

.<a href="/NIH/">NIH</a> posted updated data for research funding vs disease burden for 74 diseases.

Since the first analyses (2010), #migraine is always least funded among highest burden diseases.

If burden was the only factor, migraine funding might be &gt;13 times higher.

bit.ly/3AAvJgz
Nature Reviews Disease Primers (@diseaseprimers) 's Twitter Profile Photo

Tension-type #headache is the most prevalent neurological disorder worldwide and is characterized by recurrent headaches of mild to moderate pain intensity. go.nature.com/3feRWtw

Tension-type #headache is the most prevalent neurological disorder worldwide and is characterized by recurrent headaches of mild to moderate pain intensity. 

go.nature.com/3feRWtw
Human Migraine Research Unit (@hmru_cph) 's Twitter Profile Photo

The 1st International Conference on Advances in #Migraine Sciences (ICAMS) will be held in Copenhagen from March 10-12, 2022. ICAMS 2022 is a hybrid event that provides both in-person and online participation. Conference participation is free of charge at icams2022.com

The 1st International Conference on Advances in #Migraine Sciences (ICAMS) will be held in Copenhagen from March 10-12, 2022. ICAMS 2022 is a hybrid event that provides both in-person and online participation. Conference participation is free of charge at icams2022.com
Renato Arruda (@arrudarenato) 's Twitter Profile Photo

evidence.nejm.org NEJM Evidence! Innovative research, bold ideas in clinical trial design and clinical decision-making. Just in time! NEJM Evidence

Nature Reviews Disease Primers (@diseaseprimers) 's Twitter Profile Photo

An entire #migraine attack may last up to 7 days including, in many patients, a prodromal phase, aura, #headache and associated symptoms, and a postdromal phase. go.nature.com/3zUcVtS

An entire #migraine attack may last up to 7 days including, in many patients, a prodromal phase, aura, #headache and associated symptoms, and a postdromal phase. 

go.nature.com/3zUcVtS
Renato Arruda (@arrudarenato) 's Twitter Profile Photo

Jokes aside, such an important issue we should keep in our agendas for the times are coming... youtube.com/watch?v=ukAkG6…

Human Migraine Research Unit (@hmru_cph) 's Twitter Profile Photo

One week left until the 1st International Conference on Advances in Migraine Sciences (ICAMS) endorsed by the International Headache Society and European Headache Federation. We aim to meet the needs of colleagues worldwide interested in #migraine. Registration is free of charge at icams2022.com

One week left until the 1st International Conference on Advances in Migraine Sciences (ICAMS) endorsed by the <a href="/ihs_official/">International Headache Society</a> and <a href="/EHF_Official/">European Headache Federation</a>. We aim to meet the needs of colleagues worldwide interested in #migraine. Registration is free of charge at icams2022.com
Eric Topol (@erictopol) 's Twitter Profile Photo

Just published @nature The impact of #Covid on the brain: the 1st longitudinal imaging study before and after infection, with controls nature.com/articles/s4158… Reduction of grey matter, brain size, cognitive decline

Just published @nature
The impact of #Covid on the brain: the 1st longitudinal imaging study before and after infection, with controls
nature.com/articles/s4158…
Reduction of grey matter, brain size, cognitive decline
OneNeurology (@oneneurology_) 's Twitter Profile Photo

With 1/3 people affected by a neurological disease during their lifetime, now is the time to act for better public health outcomes. That’s why we’re supporting the #GlobalActionPlan on #Epilepsy & Neurological Disorders: oneneurology.net/gap-adoption/ ✅ #WHA75 #Neurology #OneNeurology

With 1/3 people affected by a neurological disease during their lifetime, now is the time to act for better public health outcomes. That’s why we’re supporting the #GlobalActionPlan on #Epilepsy &amp; Neurological Disorders:
oneneurology.net/gap-adoption/ ✅
#WHA75 #Neurology #OneNeurology
Elie Akl (@elie__akl) 's Twitter Profile Photo

Delighted to share our framework for defining, categorizing, and assessing conflicts of interest #COI in health #research pubmed.ncbi.nlm.nih.gov/35697333/ Gordon H. Guyatt Maram Hakoum Assem Khamis Joanne Khabsa 🧵

HenrikSchytz (@henrikschytz) 's Twitter Profile Photo

Congratulations to the new Masters of Headache Disorders 2022. It was a pleasure to meet and follow you. Thank you to the excellent staff and faculty behind the program! Rigmor H. Jensen University of Copenhagen Rigshospitalet mhd.ku.dk Faisal Mohammad Amin Messoud Ashina

Congratulations to the new Masters of Headache Disorders 2022. It was a pleasure to meet and follow you. Thank you to the excellent staff and faculty behind the program! <a href="/rj_rigmor/">Rigmor H. Jensen</a> <a href="/uni_copenhagen/">University of Copenhagen</a> <a href="/Rigshospitalet/">Rigshospitalet</a> mhd.ku.dk <a href="/drfa_CPH/">Faisal Mohammad Amin</a> <a href="/MessoudAshina/">Messoud Ashina</a>
International Headache Society (@ihs_official) 's Twitter Profile Photo

Join the International Headache Congress in Seoul for a vibrant, educational, clinical and scientific opportunity that rises the sun over #headache conditions! American Academy of Neurology @EHF_official @AHSheadache European Academy of Neurology #migraine #neurology #ClusterHeadache #CGRP #botox #neuroscience

NewYork-Presbyterian (@nyphospital) 's Twitter Profile Photo

This #WorldAutismDay and every day, #NYP strives to build a more inclusive society. Dr. Stephen Kanne explains that autism is not a linear spectrum but a multidimensional profile of strengths and challenges: bit.ly/3ZyKahy Columbia Medicine, Weill Cornell Medicine

This #WorldAutismDay and every day, #NYP strives to build a more inclusive society. Dr. Stephen Kanne explains that autism is not a linear spectrum but a multidimensional profile of strengths and challenges: bit.ly/3ZyKahy <a href="/ColumbiaMed/">Columbia Medicine</a>, <a href="/WeillCornell/">Weill Cornell Medicine</a>